Earnings Scheduled For May 10, 2022
Companies Reporting Before The Bell
• The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows.
Interesting Highlights From Today's 52-Week Lows
Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
Anavex Life Sciences Highlights Biomarker Data From Parkinson’s Disease Dementia At International Conference
Anavex Life Sciences Corp (NASDAQ:AVXL) has announced the presentation of Phase 2 clinical biomarker data from the ANAVEX2-73-PDD-001 Parkinson’s Disease Dementia…
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
Here's a roundup of top developments in the biotech space over the last 24 hours:
Recap: Anavex Life Sciences Q1 Earnings
Anavex Life Sciences (NASDAQ:AVXL) reported its Q1 earnings results on Wednesday, February 9, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings Scheduled For February 9, 2022
Companies Reporting Before The Bell
• Equinor (NYSE:EQNR) is projected to report quarterly earnings at $0.63 per share on revenue of $25.05 billion.
Anavex Life Sciences Offers Supplemental Info On ANAVEX2-73 AVATAR Phase 3 Trial For Treatment Of Adult Patients With Rett Syndrome
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and
HC Wainwright & Co. Maintains Buy on Anavex Life Sciences, Raises Price Target to $42
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and raises the price target from $39 to $42.